questionsmedicales.fr
Glucides
Oses acides
Acides uroniques
Glucuronates
Glucuronides
Glucuronides : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Analyse urinaire
Glucuronides
Spectrométrie de masse
Chromatographie
Liquides biologiques
Glucuronides
Symptômes
5
Jaunisse
Troubles hépatiques
Effets secondaires
Médicaments
Foie
Dysfonction hépatique
Douleurs abdominales
Malaises
Tests hépatiques
Symptômes digestifs
Prévention
5
Examens réguliers
Anomalies métaboliques
Hygiène de vie
Détoxification
Suivi médical
Santé hépatique
Traitements
5
Intoxication
Détoxification
Médicaments
Formation de glucuronides
Traitements naturels
Fonction hépatique
Médecin
Symptômes hépatiques
Complications
5
Lésions hépatiques
Troubles métaboliques
Maladies chroniques
Maladies hépatiques
Système immunitaire
Vulnérabilité
Détoxification
Dysfonctionnements organiques
Facteurs de risque
5
Alcoolisme
Maladies hépatiques
Maladies métaboliques
Métabolisme
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Glucuronides : Questions médicales les plus fréquentes",
"headline": "Glucuronides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Glucuronides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-08",
"dateModified": "2025-05-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Glucuronides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Glucuronates",
"url": "https://questionsmedicales.fr/mesh/D005965",
"about": {
"@type": "MedicalCondition",
"name": "Glucuronates",
"code": {
"@type": "MedicalCode",
"code": "D005965",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.811.922.162"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Glucuronides",
"alternateName": "Glucuronides",
"code": {
"@type": "MedicalCode",
"code": "D020719",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ming Hu",
"url": "https://questionsmedicales.fr/author/Ming%20Hu",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204, USA. mhu@uh.edu."
}
},
{
"@type": "Person",
"name": "Moshe Finel",
"url": "https://questionsmedicales.fr/author/Moshe%20Finel",
"affiliation": {
"@type": "Organization",
"name": "Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland."
}
},
{
"@type": "Person",
"name": "Yifan Tu",
"url": "https://questionsmedicales.fr/author/Yifan%20Tu",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204, USA."
}
},
{
"@type": "Person",
"name": "Taijun Yin",
"url": "https://questionsmedicales.fr/author/Taijun%20Yin",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204, USA."
}
},
{
"@type": "Person",
"name": "Raoul Walther",
"url": "https://questionsmedicales.fr/author/Raoul%20Walther",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Aarhus University, Aarhus, Denmark."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Completeness of variables in Hospital-Based Cancer Registries for prostatic malignant neoplasm.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39082550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0034-7167-2023-0467"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hepatic Small Vessel Neoplasm Mimics Prostate Cancer on 18 F-DCFPyl PET/CT.",
"datePublished": "2023-01-14",
"url": "https://questionsmedicales.fr/article/36728165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000004554"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36572885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12957-022-02841-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The influence of prostate volume on clinical parameters in prostate cancer screening.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36098911",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcla.24700"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Glucides",
"item": "https://questionsmedicales.fr/mesh/D002241"
},
{
"@type": "ListItem",
"position": 3,
"name": "Oses acides",
"item": "https://questionsmedicales.fr/mesh/D013400"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides uroniques",
"item": "https://questionsmedicales.fr/mesh/D014574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Glucuronates",
"item": "https://questionsmedicales.fr/mesh/D005965"
},
{
"@type": "ListItem",
"position": 6,
"name": "Glucuronides",
"item": "https://questionsmedicales.fr/mesh/D020719"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Glucuronides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Glucuronides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Glucuronides",
"description": "Comment détecte-t-on les glucuronides dans le corps ?\nQuels tests sont utilisés pour mesurer les glucuronides ?\nLes glucuronides sont-ils visibles sur une échographie ?\nPeut-on mesurer les glucuronides dans les liquides biologiques ?\nQuels biomarqueurs sont associés aux glucuronides ?",
"url": "https://questionsmedicales.fr/mesh/D020719?mesh_terms=Prostatic+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Glucuronides",
"description": "Quels symptômes indiquent une accumulation de glucuronides ?\nLes glucuronides causent-ils des effets secondaires ?\nComment les glucuronides affectent-ils le foie ?\nLes glucuronides sont-ils liés à des douleurs abdominales ?\nQuels signes cliniques sont associés aux glucuronides ?",
"url": "https://questionsmedicales.fr/mesh/D020719?mesh_terms=Prostatic+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Glucuronides",
"description": "Comment prévenir l'accumulation de glucuronides ?\nLes examens réguliers aident-ils à prévenir les problèmes de glucuronides ?\nUne bonne hygiène de vie prévient-elle les problèmes de glucuronides ?\nLes vaccinations influencent-elles les niveaux de glucuronides ?\nLe suivi médical est-il important pour la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D020719?mesh_terms=Prostatic+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Glucuronides",
"description": "Comment traiter une intoxication par glucuronides ?\nY a-t-il des médicaments pour réduire les glucuronides ?\nLes changements alimentaires aident-ils à gérer les glucuronides ?\nLes traitements naturels sont-ils efficaces contre les glucuronides ?\nQuand consulter un médecin pour des problèmes de glucuronides ?",
"url": "https://questionsmedicales.fr/mesh/D020719?mesh_terms=Prostatic+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Glucuronides",
"description": "Quelles complications peuvent survenir avec des glucuronides élevés ?\nLes glucuronides peuvent-ils causer des maladies chroniques ?\nComment les glucuronides affectent-ils le système immunitaire ?\nLes glucuronides sont-ils liés à des cancers ?\nQuelles sont les conséquences d'une détoxification inadéquate ?",
"url": "https://questionsmedicales.fr/mesh/D020719?mesh_terms=Prostatic+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Glucuronides",
"description": "Quels facteurs augmentent le risque d'accumulation de glucuronides ?\nL'âge influence-t-il les niveaux de glucuronides ?\nLe sexe joue-t-il un rôle dans les niveaux de glucuronides ?\nLes maladies métaboliques augmentent-elles le risque ?\nLe mode de vie influence-t-il les niveaux de glucuronides ?",
"url": "https://questionsmedicales.fr/mesh/D020719?mesh_terms=Prostatic+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on les glucuronides dans le corps ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les glucuronides sont souvent détectés par des analyses urinaires ou sanguines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer les glucuronides ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de chromatographie et de spectrométrie de masse sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les glucuronides sont-ils visibles sur une échographie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les glucuronides ne sont pas visibles sur une échographie, car ce sont des molécules."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les glucuronides dans les liquides biologiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être mesurés dans l'urine, le sang et d'autres liquides biologiques."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont associés aux glucuronides ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les biomarqueurs incluent des métabolites spécifiques détectés dans les analyses."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une accumulation de glucuronides ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une accumulation peut provoquer des symptômes comme la jaunisse ou des troubles hépatiques."
}
},
{
"@type": "Question",
"name": "Les glucuronides causent-ils des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains glucuronides peuvent entraîner des effets secondaires liés aux médicaments."
}
},
{
"@type": "Question",
"name": "Comment les glucuronides affectent-ils le foie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent influencer le métabolisme hépatique et provoquer des dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Les glucuronides sont-ils liés à des douleurs abdominales ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une accumulation excessive peut causer des douleurs abdominales et des malaises."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés aux glucuronides ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des anomalies dans les tests hépatiques et des symptômes digestifs."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'accumulation de glucuronides ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez l'usage excessif de médicaments et maintenez une bonne hydratation."
}
},
{
"@type": "Question",
"name": "Les examens réguliers aident-ils à prévenir les problèmes de glucuronides ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent détecter des anomalies métaboliques précocement."
}
},
{
"@type": "Question",
"name": "Une bonne hygiène de vie prévient-elle les problèmes de glucuronides ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hygiène de vie saine contribue à un métabolisme efficace et à la détoxification."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les niveaux de glucuronides ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent protéger le foie, influençant indirectement les glucuronides."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important pour la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier aide à surveiller la santé hépatique et les métabolites."
}
},
{
"@type": "Question",
"name": "Comment traiter une intoxication par glucuronides ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure l'hydratation, des médicaments pour soutenir le foie et la détoxification."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments pour réduire les glucuronides ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent aider à réduire la formation de glucuronides dans le corps."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires aident-ils à gérer les glucuronides ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut soutenir le métabolisme et réduire l'accumulation."
}
},
{
"@type": "Question",
"name": "Les traitements naturels sont-ils efficaces contre les glucuronides ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains traitements naturels peuvent aider à soutenir la fonction hépatique et la détoxification."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des problèmes de glucuronides ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si vous présentez des symptômes hépatiques ou digestifs persistants."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des glucuronides élevés ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des lésions hépatiques, des troubles métaboliques et des infections."
}
},
{
"@type": "Question",
"name": "Les glucuronides peuvent-ils causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut contribuer à des maladies hépatiques chroniques."
}
},
{
"@type": "Question",
"name": "Comment les glucuronides affectent-ils le système immunitaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une accumulation peut affaiblir le système immunitaire, rendant l'organisme vulnérable."
}
},
{
"@type": "Question",
"name": "Les glucuronides sont-ils liés à des cancers ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre des métabolites et le développement de cancers hépatiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une détoxification inadéquate ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une détoxification inadéquate peut entraîner une accumulation toxique et des dysfonctionnements organiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'accumulation de glucuronides ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'usage excessif de médicaments, l'alcoolisme et les maladies hépatiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les niveaux de glucuronides ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter le métabolisme et l'élimination des glucuronides."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans les niveaux de glucuronides ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des différences hormonales peuvent influencer le métabolisme des glucuronides."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies métaboliques peuvent perturber le métabolisme des glucuronides."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il les niveaux de glucuronides ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter les niveaux."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/05/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204, USA. mhu@uh.edu.
Publications dans "Glucuronides" :
3 publications dans cette catégorie
Affiliations :
Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204, USA.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204, USA.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Aarhus University, Aarhus, Denmark.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Science, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, USA.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. Electronic address: geguangbo@shutcm.edu.cn.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutics, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Program in Pharmacology and Drug Development, Tufts University Graduate School of Biomedical Science and School of Medicine, Boston, MA, USA.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Program in Pharmacology and Drug Development, Tufts University Graduate School of Biomedical Science and School of Medicine, Boston, MA, USA.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, People's Republic of China.
TriApex Laboratories Co., Ltd, Nanjing, People's Republic of China.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
TriApex Laboratories Co., Ltd, Nanjing, People's Republic of China.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
TriApex Laboratories Co., Ltd, Nanjing, People's Republic of China.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, People's Republic of China.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, People's Republic of China.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Department of Legal Medicine, Toxicology, University Medical Center Hamburg-Eppendorf, Butenfeld 34, Hamburg 22529, Germany.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Department of Legal Medicine, Toxicology, University Medical Center Hamburg-Eppendorf, Butenfeld 34, Hamburg 22529, Germany.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, College of Pharmacy , Washington State University , Spokane Washington 99210 , United States.
Publications dans "Glucuronides" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, College of Pharmacy , Washington State University , Spokane Washington 99210 , United States.
Publications dans "Glucuronides" :
to analyze the completeness of variables from Hospital-Based Cancer Registries of cases of prostate neoplasm in the Oncology Care Network of a Brazilian state between 2000 and 2020....
an ecological time series study, based on secondary data on prostate cancer Hospital-Based Cancer Registries prostate. Data incompleteness was classified as excellent (<5%), good (between 5%-10%), fai...
there were 13,519 cases of prostate cancer in the Hospital-Based Cancer Registries analyzed. The variables "family history of cancer" (p<0.001), "alcoholism" (p<0.001), "smoking" (p<0.001), "TNM stagi...
most Hospital-Based Cancer Registries variables showed excellent completeness, but important variables had high percentages of incompleteness, such as TNM and clinical staging, in addition to alcoholi...
18 F-DCFPyl is a Food and Drug Administration-approved radiotracer that targets prostate-specific membrane antigen and is used in the detection of recurrent or metastatic prostate cancer. As its use h...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
The optimal treatment of metastatic castration-resistant prostate cancer (mCRPC) continues to be challenging, given the multitude of life prolonging treatment options. Radionuclide therapy delivers co...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa) are current clinical challenges....
The serum metabolites of 20 healthy individuals and patients with prostatitis, BPH, or PCa were identified using untargeted liquid chromatography-mass spectrometry (LC-MS). In addition, targeted LC-MS...
Organic acid metabolites had good sensitivity and specificity in differentiating prostatitis, BPH, and PCa. Three diagnostic models identified patients with PROSTATITIS: phenyllactic acid (area under ...
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...